FDA Brief

Warning letters Drugs

FDA warning letter to

Sprout Health Partners LLC dba Sprout Health

LowIssued Sep 9, 2025Posted Sep 16, 2025Center for Drug Evaluation and Research (CDER)

FDA warned telehealth seller Sprout Health that its website's claim compounded semaglutide and tirzepatide are FDA-approved makes the drugs misbranded.

What happened

FDA reviewed the website joinsprouthealth.com in August 2025 and found it offers compounded semaglutide and tirzepatide drug products. The site states that "GLP-1 medications are FDA-approved and backed by extensive clinical research," but compounded drugs are not FDA-approved. FDA says the statement is false or misleading and therefore misbrands the products.

What FDA found

  1. The website says its GLP-1 drugs are FDA-approved, which is false for compounded drugs, so the labeling is misleading.

    FDCA section 502(a) [21 U.S.C. § 352(a)]
  2. Advertising or promoting a compounded drug with false or misleading claims misbrands that drug.

    FDCA section 502(bb) [21 U.S.C. § 352(bb)]
  3. Selling these misbranded drugs across state lines is a prohibited act.

    FDCA section 301(a) [21 U.S.C. § 331(a)]
  4. Receiving misbranded drugs in interstate commerce, or delivering them, is also prohibited.

    FDCA section 301(c) [21 U.S.C. § 331(c)]

What FDA wants

FDA tells the company to stop using the misleading FDA-approval language immediately and to send a written response within 15 working days describing the corrective steps taken and how it will prevent repeat violations, with supporting documents.

Who should pay attention

  • telehealth platforms selling compounded GLP-1 drugs
  • compounding pharmacies that supply online prescribers
  • marketing and compliance teams that write drug product website copy

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. New Green Nutrition Inc.

    FDA says New Green Nutrition sold unapproved drugs online, and its Qu Feng Huo Luo Dan contained hidden dexamethasone.

    High risk
  2. Ong Tien USA LLC

    FDA warned Ong Tien USA LLC that its herbal joint products are unapproved drugs and one contained hidden piroxicam and dexamethasone.

    High risk
  3. Bella’s Nutri Shop Inc.

    Bella’s Nutri Shop sells “Tawon Liar” as an unapproved drug with hidden dexamethasone, tapentadol, and meloxicam.

    High risk
  4. RonanRx, Inc. dba RonanRx

    FDA says RonanRx's website and X posts misbrand compounded semaglutide and tirzepatide with false or misleading claims.

    Low